Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

Classification Complications: Will Gig Workers Enter the Workers’ Comp Market?

Legislation could reclassify gig workers as employees, which could entitle them to benefits
Winter 2021/2022

The Long Haul: Chronic Health Complications of COVID-19

Those previously infected by coronavirus may face long-term health complications, potentially complicating workers' comp claims
Winter 2021/2022

Out of Balance: Workforce Gender Disparities and What They Mean for Workers’ Comp

Adverse effects of the pandemic on women, the workforce, and workers' comp
Winter 2021/2022

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

FDA Approves First Test to Help Identify Risks of Developing Opioid Use Disorder

The AvertD test is intended to be used prior to first exposure to oral opioids in patients considered for a 4-30 day prescription for acute pain.
Feb 2024

Department of Health and Human Services Reveals Cannabis Rescheduling Findings

With many federal agencies in alignment, the ultimate decision rests with the DEA.
Feb 2024

FDA Issues Respective Warnings for Compounded and Counterfeit Semaglutide

The growing demand for this drug has led individuals to search for semaglutide from alternative sources.
Jan 2024

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

COVID-19 and Clinical Trials

COVID-19 drug trials are underway, but the pandemic is disrupting clinical testing.
Mar 2020

JAMA Compares Effectiveness of Treatment Pathways for Opioid Use Disorder

A study of 41,000 adults finds that only treatment with buprenorphine or methadone reduced risk of overdose.
Mar 2020

WCIRB Publishes Physical Medicine Report

An analysis of 1.5 million claims found early physical therapy lowers odds of opioid use by 14%.
Feb 2020
1 14 15 16 17 18 25

Whitepapers

lockenvelopephone-handsetmagnifiermenucross-circle